One of the most common questions people ask about GLP-1 weight loss treatment is: "Do I qualify?"
While every provider has their own criteria, the general guidelines are based on Body Mass Index (BMI), a widely used screening tool that estimates body fat based on your height and weight.
Let's break down what these numbers mean and whether you might qualify.
What Is BMI?
BMI (Body Mass Index) is a simple calculation that uses your height and weight to estimate body fat. While it has limitations, it doesn't account for muscle mass, bone density, or body composition, it's the standard screening tool used by healthcare providers to assess weight-related health risks.
How to Calculate Your BMI
Formula: BMI = (weight in pounds ÷ height in inches squared) × 703
*Quick reference:*
- A person who is 5'5" and weighs 180 pounds has a BMI of approximately 30
- A person who is 5'8" and weighs 200 pounds has a BMI of approximately 30
BMI Categories
- Below 18.5: Underweight
- 18.5 - 24.9: Healthy weight
- 25.0 - 29.9: Overweight
- 30.0 - 34.9: Obesity Class I
- 35.0 - 39.9: Obesity Class II
- 40.0 and above: Obesity Class III (severe obesity)
What BMI Do You Need for GLP-1 Treatment?
The standard clinical criteria for GLP-1 weight loss medication are based on FDA-approved guidelines from the STEP trials:
You likely qualify if:
Option A: Your BMI is 30 or higher (any weight-related condition is helpful but not required)
Option B: Your BMI is 27 or higher with at least one weight-related health condition, such as:
- Type 2 diabetes or prediabetes
- High blood pressure (hypertension)
- High cholesterol (dyslipidemia)
- Obstructive sleep apnea
- Non-alcoholic fatty liver disease
- Joint pain or osteoarthritis related to weight
These thresholds come directly from the clinical trials that led to FDA approval of Wegovy in 2021.
BMI Is Just One Piece of the Puzzle
While BMI is the primary screening tool for GLP-1 eligibility, it's not the only factor your doctor will consider:
Other Factors That Matter
- Medical history: Any conditions that might affect treatment safety
- Current medications: Possible drug interactions
- Previous weight loss attempts: History of diet and exercise efforts
- Waist circumference: Sometimes used as an additional measure of abdominal fat
- Metabolic health markers: Blood sugar, cholesterol, blood pressure
What If Your BMI Is Below the Threshold?
If your BMI is under 27, GLP-1 medications are not currently FDA-approved for weight loss in your range. However, you should still speak with a healthcare provider about other evidence-based weight loss approaches that might work for you.
Can You Take GLP-1 Medications If Your BMI Is Higher Than 40?
Yes, a higher BMI does not rule out treatment. What improvement looks like varies by person, and related conditions such as joint pain, sleep apnea, and blood sugar are part of what a physician weighs and monitors during treatment.
Calculating Your BMI at Home
You can calculate your BMI in seconds using a simple formula or online calculator. Here's the manual method:
- Weigh yourself in pounds
- Measure your height in inches
- Divide your weight by your height squared
- Multiply by 703
For example, someone who is 5'7" (67 inches) and weighs 210 pounds:
- 67 × 67 = 4,489
- 210 ÷ 4,489 = 0.0468
- 0.0468 × 703 = BMI of 32.9
A BMI of 32.9 falls in Obesity Class I. BMI is one screening input; whether GLP-1 treatment is appropriate is always a licensed physician's decision.
What If BMI Doesn't Tell the Whole Story?
Some people, particularly athletes or people with high muscle mass, may have a high BMI but low body fat percentage. Others may have a normal BMI but carry excess abdominal fat (which poses health risks).
That's why a thorough medical evaluation considers more than just your BMI. Your doctor will look at your whole picture.
Ready to Find Out If You Qualify?
The best way to know if GLP-1 treatment is right for you is to speak with a licensed physician.
Start your 2-minute medical assessment to connect with a licensed physician who can evaluate your complete health profile and determine if GLP-1 treatment is appropriate.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider. Individual results may vary.
Frequently Asked Questions
What BMI do you need to qualify for GLP-1?
FDA labeling for weight-management GLP-1 medications (Wegovy and Zepbound) covers adults with a body mass index of 30 or higher (obesity), or 27 or higher (overweight) with at least one weight-related condition. Qualifying weight-related conditions include type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, polycystic ovary syndrome, and nonalcoholic fatty liver disease. The final eligibility decision is made by a US-licensed physician based on full medical history.
Can I get GLP-1 if my BMI is below 30?
Yes, if your BMI is 27 or higher and you have at least one weight-related health condition (such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea). If your BMI is below 27, GLP-1 medications are not appropriate as a weight loss tool under labeled indications. A physician may consider off-label prescribing in narrow clinical scenarios (such as patients with metabolic syndrome who do not fit standard BMI categories), but this is uncommon and individualized.
How do I calculate my BMI for GLP-1 eligibility?
BMI = weight (kg) divided by height (m) squared. Or in US units: weight (lb) times 703, divided by height (in) squared. A simpler shortcut: a 5 foot 4 inch adult weighing 175 pounds has a BMI of 30. A 5 foot 9 inch adult weighing 183 pounds has a BMI of 27. Online BMI calculators (including ours at /tools/bmi-calculator) compute it instantly. BMI is a screening tool, not a complete clinical picture; muscle mass, age, and body composition all matter for the final eligibility decision.
What other factors matter for GLP-1 eligibility besides BMI?
Contraindications matter as much as BMI. A physician evaluates personal and family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, prior pancreatitis, severe gastroparesis, current pregnancy or planned pregnancy, severe kidney disease, severe gallbladder disease, and active diabetic retinopathy. Current medications also matter, especially insulin and sulfonylureas (which increase hypoglycemia risk on GLP-1) and oral contraceptives (which may have absorption affected by delayed gastric emptying).
Can teenagers or older adults qualify for GLP-1?
Adolescents 12 and older with obesity (BMI 95th percentile or higher) are FDA-approved for Wegovy and Saxenda. Adults 65 and older can be prescribed GLP-1 medications, though physicians weigh additional factors including frailty, sarcopenia risk from rapid weight loss, kidney function, and overall life expectancy when deciding. Most reputable telehealth providers restrict prescribing to adults 18 to roughly 75; outside that range, in-person specialty care is usually more appropriate.
Majesta Health medical content is written against primary sources (FDA labels, peer-reviewed trials, HHS and CDC publications) and passes a documented compliance review before publication. We are rolling out named physician review with US-licensed clinicians from our partner MD Integrations (MDI): each reviewed article will show the reviewing physician's name, NPI, and review date.
- US-licensed physicians affiliated with our clinical partner MD Integrations
- Practicing in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across the states we currently serve through the MD Integrations Medical Services Organization (coverage varies by state; see our states page)
- Dispensing pharmacy partner: Belmar Pharma Solutions; Majesta prescriptions are dispensed through Belmar's state-licensed 503A compounding pharmacy